期刊文献+

慢性乙型肝炎肝组织糜酶活性与肝纤维化相关性研究 被引量:1

Correlation between chymase activity and liver fibrosis in liver tissues of patients with chronic hepatitis B.
原文传递
导出
摘要 目的探讨慢性乙型肝炎患者肝组织糜酶活性与肝纤维化相关性。方法收集2009年1月至2012年3月延边大学附属医院消化科住院的慢性乙型肝炎患者46例,按肝脏病理肝纤维分级(S1~S4)进行分组,S1组10例,S2组15例,S3组15例,S4组6例;采用酶联免疫吸附试验(ELISA)检测肝组织中糜酶活性,采用胃酶酸解法测定肝组织胶原纤维及羟脯氨酸(HYP)含量,经Masson染色后直接测量胶原纤维面积与视野总面积比值,以该比值作为胶原纤维的相对含量。观察比较各组肝组织糜酶活性、胶原纤维含量和HYP含量。结果 S3组和S4组肝组织糜酶活性、肝脏胶原纤维含量及HYP含量均较S1组、S2组明显升高,差异有统计学意义(P<0.01),且纤维化程度重组(S3+S4)肝组织糜酶活性、胶原纤维含量及HYP含量明显高于纤维化轻组(S1+S2)(P<0.01);肝组织糜酶活性与肝组织胶原氨酸含量和HYP含量呈正相关,相关系数分别为0.685(P<0.05)和0.702(P<0.01)。结论慢性乙型肝炎患者肝组织中糜酶活性与肝组织胶原纤维含量和HYP含量呈正相关,可作为肝纤维化的评价指标之一。 Objective To study the correlation between chymase activity and liver fibrosis in liver tissues of patients with chronic hepatitis B.Methods Forty-six chronic hepatitis B cases hospitalized in our department from Jan.,2009 to March,2012 were divided into 4 groups(S1-S4).The chymase levels were determined by using the method of enzyme linked immunosorbant assay(ELISA).The contents of collagen fibrosis and HYP were detected by using the gastric enzyme method.The Masson staining was applied to measure field area and the total area of collagen fibers and their ratio.This ratio was considered as the relative amounts of collagen fibers.Chymase activity,contents of HYP and contents of collagen fibrosis were observed and compared.Results The levels of hepatic chymase,collagen fibrosis and HYP were significantly higher in S3 and S4 than in S1 and S2(P < 0.01).In addition,the levels of hepatic chymase,collagen fibrosis and HYP were higher advanced fibrosis groups(S3 + S4) than those in the mild fibrosis groups(S1 + S2)(P < 0.01).There was positive correlation between hepatic chymase levels and the levels of collagen fibrosis(r = 0.685,P < 0.05) or hydroxyproline(r =0.702,P < 0.01).Conclusion Chymase levels were positively correlated with those of the collagen fibrosis and HYP,and thus can be considered as an index for hepatic fibrosis in chronic hepatitis.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2013年第7期540-542,共3页 Chinese Journal of Practical Internal Medicine
基金 国家自然科学基金项目(30960372)
关键词 慢性乙型肝炎 糜酶 胶原纤维 羟脯氨酸 肝纤维化 chymase chronic hepatitis collagen fibrosis hydroxyproline hepatic fibrosis
  • 相关文献

参考文献11

  • 1毕红征,杜春燕,黄国钧.HG颗粒对肝纤维化大鼠肝脏胶原纤维及羟脯氨酸含量的影响[J].郑州大学学报(医学版),2007,42(3):526-528. 被引量:6
  • 2尹明实,朴红心,周振霞,韩学吉,太永日.肝组织中糜酶浓度在慢性肝炎肝纤维化中的意义[J].中国免疫学杂志,2006,22(9):876-877. 被引量:3
  • 3张晶,李定国,刘清华,尤汉宁,宗春华,陆汉明.血管紧张素Ⅱ抑制大鼠肝星形细胞的凋亡[J].上海第二医科大学学报,2004,24(3):189-191. 被引量:10
  • 4王卫卫,杨希山,李旭,王捷,田野,杨传红,赖晃文.血管紧张素Ⅱ1型受体在肝纤维化形成过程中表达变化的研究[J].中华消化杂志,2004,24(3):131-134. 被引量:9
  • 5Takai S,,Jin D,Ikeda H, et al.Significance of angiotensin II receptor blockers with high affinity to angiotensin II type1receptors for vascular protection inrats. Hypertension Research . 2009
  • 6Hagel AF,Derossi T,Zopf Y,et al.Mast cell tryptaselevels in gut mucosa in patients with gastrointestinalsymptoms caused by food allergy. International Archives of Allergy and Immunology . 2012
  • 7Wang X,Chen H,Zhang M,et al.Roles of mast cells and mono-cyte chemoattractant protein-1 in the renal injury of obesity-relatedglomerulopathy. The American Journal of The Medical Sciences . 2012
  • 8Komeda K,Jin D,Takai S,et al.Significance of chymase-dependentangiotensinⅡformation in the progression of human liver fibrosis. Hepatology Research . 2008
  • 9Chinese Society of Infectious Diseases,Chinese Society of Hepa-tology of Chinese Medical Association.The programme of preventionand cure for viral hepatitis B. Zhonghua Chuanranbingxue Zazhi . 2011
  • 10Zhang S,Zeng X,Yang H,et al.Mast cell tryptase induces microgli,activation via protease-activated receotor 2 signaling. Cell Physi-ol Biochem . 2012

二级参考文献19

  • 1王丽春,赵连三.肝纤维化的实验动物模型[J].中国实验动物学报,2004,12(4):246-250. 被引量:27
  • 2汪少林,芦秀琴,汪培玲,王凤文,汪汉.中医药抗肝纤维化研究概况[J].甘肃中医学院学报,2005,22(2):50-52. 被引量:11
  • 3王晓萍,周语平.肝纤维化动物模型制作的研究进展[J].甘肃中医,2006,19(1):13-15. 被引量:9
  • 4Yoshikawa H,Tasaka K.Suppression of mast cell activation by glucocorticoid[J].Arch Immunol Ther Exp (Wars2),2000; 48:487-495.
  • 5Satomura K,Shimizu S,Nagato T et al.Establishiment of an assay method for human mast cell chymase[J].Hepatol Res,2002;24:361-367.
  • 6Yoshikawa H,Tasaka K.Suppression of mast cell activation by glucocorticoid[J].Arch Immunol Ther Exp (Wars2),2000; 48:487-495.
  • 7Ginsburg H,Ben-David E.Mast cell growth on fibroblast monolayers:two-cell entities[J].Immunology,1998; 45:371-380.
  • 8Farrell D J,Hines J E,Walls A F et al.Intrahepatic mast cells in chronic liver disease[J].Hepatology,1995; 22:1175-1181.
  • 9Tani K,Ogushi F,Kawano T et al.Chymase is a potent chemoattractant for human monocytes an neutrophils[J].J leukoc Biol,2000;67:585-589.
  • 10Yoshiji H,Kuriyama S,Yoshi J et al.Angiotensin Ⅱ type 1 receptor interaction is a major for liver fibrosis development in rats[J].Hepatology,2001; 34:745-747.

共引文献23

同被引文献10

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部